Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression

BACKGROUND: The majority of colorectal carcinomas (CRCs) are insensitive to programmed death protein-1/programmed death-ligand 1 (anti-PD-1/PD-L1) immune checkpoint inhibitor (ICI) antibodies. While there are many causes for ICI insensitivity, recent studies suggest that suppression of innate immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Bin-Jin, Tsao, Li-Chung, Acharya, Chaitanya R, Trotter, Timothy, Agarwal, Pankaj, Wei, Junping, Wang, Tao, Yang, Xiao-Yi, Lei, Gangjun, Osada, Takuya, Lyerly, Herbert Kim, Morse, Michael A, Hartman, Zachary Conrad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncolytic and Local Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971789/
https://www.ncbi.nlm.nih.gov/pubmed/35361727
http://dx.doi.org/10.1136/jitc-2021-003721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971789/
https://www.ncbi.nlm.nih.gov/pubmed/35361727
http://dx.doi.org/10.1136/jitc-2021-003721

Ejemplares similares